Cargando...

Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis

BACKGROUND: A significant proportion of patients with severe asthma may also suffer from nasal polyposis, which is commonly defined as chronic rhinosinusitis with nasal polyps (CRSwNP), the presence of which may adversely affect asthma treatment outcomes. The biologic agent omalizumab is effective a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Transl Allergy
Main Authors: Heffler, Enrico, Saccheri, Fabiana, Bartezaghi, Marta, Canonica, Giorgio Walter
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2020
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7318524/
https://ncbi.nlm.nih.gov/pubmed/32607141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13601-020-00330-1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!